+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Should aspirin be used for the primary prevention of cardiovascular disease in people with diabetes?



Should aspirin be used for the primary prevention of cardiovascular disease in people with diabetes?



Medical Journal of Australia 190(11): 614-615




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 055763289

Download citation: RISBibTeXText

PMID: 19485837


Related references

Aspirin for primary prevention of cardiovascular events in people with diabetes. Journal of the American College of Cardiology 55(25): 2878-2886, 2010

Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease?. New Zealand Medical Journal 131(1484): 19-25, 2018

Which people should take aspirin for primary prevention of cardiovascular disease?. Therapeutics and Clinical Risk Management 11: 1043-1045, 2015

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. Bmj 339: B4531, 2009

Aspirin for primary prevention of cardiovascular disease in diabetes. Journal of Diabetes Investigation 2019, 2019

Aspirin for primary prevention of vascular disease in people with diabetes. Bmj 339: B4596, 2009

Primary and secondary prevention of cardiovascular disease in diabetes with aspirin. Diabetes and Vascular Disease Research 9(4): 243-244, 2013

Aspirin for primary prevention of cardiovascular disease events in diabetes: the balancing act?. Journal of the Royal College of Physicians of Edinburgh 48(4): 332-333, 2018

Aspirin therapy and primary prevention of cardiovascular disease in diabetes mellitus. Diabetes, Obesity and Metabolism 11(11): 997-1000, 2011

Preventing cardiovascular disease in patients with diabetes: use of aspirin for primary prevention. Current Cardiology Reports 17(3): 566, 2015

Aspirin for primary prevention of cardiovascular disease in patients with diabetes: A meta-analysis. Diabetes Research and Clinical Practice 120: 31-39, 2016

Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis. Expert Opinion on PharmacoTherapy 11(9): 1459-1466, 2010

Primum non nocere: An updated meta-analysis on aspirin use in primary prevention of cardiovascular disease in patients with diabetes. European Journal of Preventive Cardiology 2019: 2047487319826439, 2019

Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins. Trials 8(): 21-21, 2007

PS41Characteristics Associated with Statin Prescribing for Primary Prevention of Cardiovascular Disease Among People with Diabetes. Journal of Epidemiology & Community Health 66(Suppl 1): A54.1-A54, 2012